Vaccination strategies for cross-protective immunity against African Horse Sickness Virus (AHSV)
<p>African Horse Sickness (AHS) is a highly lethal arboviral disease of equines. The lack of treatment makes vaccination essential. However, there are nine AHSV serotypes and AHSV immunity is serotype-specific; therefore AHSV vaccines must protect against all serotypes circulating in the field...
Autor principal: | Manning, N |
---|---|
Altres autors: | Gilbert, S |
Format: | Thesis |
Publicat: |
2017
|
Ítems similars
-
A modified vaccinia Ankara virus (MVA) vaccine expressing African horse sickness virus (AHSV) VP2 protects against AHSV challenge in an IFNAR -/- mouse model.
per: Javier Castillo-Olivares, et al.
Publicat: (2011-01-01) -
Induction of antibody responses to African horse sickness virus (AHSV) in ponies after vaccination with recombinant modified vaccinia Ankara (MVA).
per: Rachael Chiam, et al.
Publicat: (2009-06-01) -
Immune response of horses to inactivated African horse sickness vaccines
per: Marina Rodríguez, et al.
Publicat: (2020-09-01) -
Comparative immune responses after vaccination with the formulated inactivated African horse sickness vaccine serotype 1 between naïve horses and pretreated horses with the live-attenuated African horse sickness vaccine
per: Narongsak Chaiyabutr, et al.
Publicat: (2022-10-01) -
Genetic studies of African horse sickness virus
per: Bachanek-Bankowska, K
Publicat: (2013)